ArticleAdvanced healthcare materials2026
Anion-π Interaction-Triggered Self-Healing Zwitterionic Hydrogel as an Immunocompatible Platform for Injectable Therapies.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Zwitterionic hydrogels have attracted considerable attention for protein stabilization, cell encapsulation, and therapeutic delivery owing to their highly hydrated and bioinert nature. Nevertheless, developing injectable zwitterionic hydrogels that can form under mild and cytocompatible conditions remains a major challenge, especially for the delivery of fragile proteins and living cells. This challenge mainly stems from the weak intrinsic intermolecular interactions and limited reactive groups of zwitterionic polymers, which make it difficult to establish stable hydrogel networks without additional molecular modification or external crosslinking. Here, we report an injectable zwitterionic supramacromolecular hydrogel (SSH) formed by the spontaneous assembly of poly(methacryloyloxyethyl sulfobetaine) (PSBMA) and poly(styrenesulfonate) (PSSNa). Molecular dynamics simulations support the involvement of anion-π interactions in gelation, leading to a self-healing physically crosslinked network. SSH exhibits injectability, self-healing behavior, intrinsic antiadhesive properties, and favorable immunocompatibility. The mild gelation process enables efficient cell encapsulation and injection while maintaining high cell viability. In addition, SSH stabilizes and delivers basic fibroblast growth factor (bFGF), resulting in improved therapeutic efficacy in a diabetic wound-healing model. This work establishes a mild gelation strategy for injectable zwitterionic hydrogels and highlights their potential in biomedical delivery and cell-based therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.